Bayer Focuses On Medical Technology For Consumers With Precision Health Unit
German pharma giant says division will help people take control of their own health care with digital products.
You may also be interested in...
Bayer's head of R&D and chief scientific officer David Evendon-Challis talked to Medtech Insight about the company's prescision health business, including a holistic and personalized approach to digital self-care.
Like other big global OTC players, Bayer Consumer Health is stepping up its investment in digital self-care. In the first part of an exclusive interview, HBW Insight catches up with the company's head of R&D and chief scientific officer David Evendon-Challis to dig deeper into the rationale for setting up a new 'prescision health' business unit, including why a holistic and personalized approach to digital self-care increases trust in long-loved and science-backed brands.
Inflationary pressures and supply constraints led to volume declines at Bayer Consumer Health in Q1. However, price rises offset these headwinds helping the business to post a 4% rise in sales.